Comparative analysis of anterior lumbar interbody fusion and transforaminal lumbar interbody fusion in clinical outcomes: ALIF associated with lower rates of adjacent segment degeneration (ASD) in a long-term follow-up study
International Orthopaedics · 2025
DOI: 10.1007/s00264-025-06546-9 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Orthopaedics, 2025. Verfasst von Peipei Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Orthopedics, Xijing Hospital, The Air Force Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Spinal Fusion, Lumbar Vertebrae, Intervertebral Disc Degeneration. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: NSFC project.
Abstract (Originalsprache)
PURPOSE: To compare the long-term efficacy of anterior lumbar interbody fusion (ALIF) and posterior transforaminal lumbar interbody fusion (TLIF) in treating lumbar degenerative diseases. METHODS: A retrospective analysis was conducted on 57 patients with lumbar degenerative diseases who underwent either ALIF or TLIF from March 2003 to October 2007. Patients were divided into an ALIF group (n = 27) and a TLIF group (n = 30). Pain was evaluated using the visual analogue scale (VAS), and the Oswestry Disability Index (ODI) was used to assess clinical outcomes. Radiographic adjacent segment degeneration (rASD) was evaluated using the Modified Pfirrmann Scale. Three-dimensional CT was used to assess the fusion rate at the last follow-up. RESULTS: Follow-up duration ranged from 58 to 120 months, with an average of 90.6 months. No significant difference was observed in VAS and ODI scores between the two groups (P > 0.05). However, significant differences were noted before and after the operation (P < 0.05). The intervertebral disc height (IDH) and lumbar lordosis (LL) increased after the operation and during follow-ups. The IDH and LL in the ALIF group were significantly higher than those in the TLIF group both postoperatively and at follow-ups (P < 0.05). At the last follow-up, the incidence of rASD in the ALIF group was significantly lower than in the TLIF group (P < 0.05). CONCLUSIONS: Both ALIF and TLIF provide satisfactory long-term outcomes for lumbar degenerative diseases. ALIF more effectively restores and maintains lumbar intervertebral height and lumbar lordosis, potentially reducing the incidence of adjacent segment degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Orthopedics, Xijing Hospital, The Air Force Military Medical University, Xi'an, China.
- Department of Medical Statistics, The Air Force Military Medical University, Xi'an, China.
- Institute of Orthopedics, Xijing Hospital, The Air Force Military Medical University, Xi'an, China. Zjluo@fmmu.edu.cn.
- Institute of Orthopedics, Xijing Hospital, The Air Force Military Medical University, Xi'an, China. huxueyu1980@163.com.
Förderung
- NSFC project
Zitieren
APA
Huang, P., Ye, B., Xie, F., Zhou, J., Tan, Z., Luo, Z., & Hu, X. (2025). Comparative analysis of anterior lumbar interbody fusion and transforaminal lumbar interbody fusion in clinical outcomes: ALIF associated with lower rates of adjacent segment degeneration (ASD) in a long-term follow-up study. International Orthopaedics. https://doi.org/10.1007/s00264-025-06546-9
Vancouver
Huang P, Ye B, Xie F, Zhou J, Tan Z, Luo Z, et al. Comparative analysis of anterior lumbar interbody fusion and transforaminal lumbar interbody fusion in clinical outcomes: ALIF associated with lower rates of adjacent segment degeneration (ASD) in a long-term follow-up study. International Orthopaedics. 2025. doi:10.1007/s00264-025-06546-9
BibTeX
@article{Huang2025,
author = {Huang, Peipei and Ye, Bin and Xie, Fang and Zhou, Jie and Tan, Zhijun and Luo, Zhuojing and Hu, Xueyu},
title = {Comparative analysis of anterior lumbar interbody fusion and transforaminal lumbar interbody fusion in clinical outcomes: ALIF associated with lower rates of adjacent segment degeneration (ASD) in a long-term follow-up study},
journal = {International Orthopaedics},
year = {2025},
doi = {10.1007/s00264-025-06546-9}
}
EUVIMED